Funding · Company
Theradaptive, Inc.
Frederick, MDBiotech & Pharma
Theradaptive, Inc. of Frederick, MD has disclosed $36M across 1 Form D offering filed with the SEC on Aug 4, 2026.
$36M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$36M
Form D · Aug 4, 2026 ↗
Q3 2026
· target $78M
Filing details
HeadquartersFrederick, MDIndustryBiotech & Pharma (Biotechnology)SEC CIK0002148461Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →